Author:
Bassey-Archibong Blessing I,Rayner Lyndsay G A,Hercules Shawn M,Aarts Craig W,Dvorkin-Gheva Anna,Bramson Jonathan L,Hassell John A,Daniel Juliet M
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Reference65 articles.
1. Foulkes WD, Smith IE, Reis-Filho JS . Triple-negative breast cancer. N Engl J Med 2010; 363: 1938–1948.
2. Brouckaert O, Wildiers H, Floris G, Neven P . Update on triple-negative breast cancer: prognosis and management strategies. Int J Womens Health 2012; 4: 511–520.
3. O'Reilly EA, Gubbins L, Sharma S, Tully R, Guang MH, Weiner-Gorzel K et al. The fate of chemoresistance in triple negative breast cancer (TNBC). BBA Clin 2015; 3: 257–275.
4. Hill SJ, Clark AP, Silver DP, Livingston DM . BRCA1 pathway function in basal-like breast cancer cells. Mol Cell Biol 2014; 34: 3828–3842.
5. Hongthong K, Ratanaphan A . BRCA1-associated triple-negative breast cancer and potential treatment for ruthenium-based compounds. Curr Cancer Drug Targets 2016; 16: 606–617.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献